Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
NCT02329821
Adenocarcinoma, Carcinoma
Seoul, South Korea
View Trial DetailsNCT Number: NCT01316679
Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vanderbilt University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02329821
Adenocarcinoma, Carcinoma
Seoul, South Korea
View Trial DetailsNCT00883454
Adenocarcinoma, Carcinoma
Rozzano, Milan, Milan, Italy
View Trial DetailsNCT05233098
Adenocarcinoma, Carcinoma
Chicago, Illinois, United States
View Trial DetailsNCT02112656
Adenocarcinoma, Carcinoma
Los Angeles, California, United States
View Trial Details